OpportunityAnalyzer: Uveitis - Opportunity Analysis and Forecasts to 2017
Reportstack, provider of premium market research reports announces the addition of OpportunityAnalyzer: Uveitis - Opportunity Analysis and Forecasts to 2017 market report to its offering
Uveitis is an expanding market currently dominated by corticosteroid treatment options as well as off-label immunosuppressive and biologic drugs. Since the conventional corticosteroid treatment is only effective in 50-60% of patients a significant number of patients can be targeted with the new treatment options. While anterior uveitis patients represent the majority of patients, all but...
View full press release